Skip to main content

. 1981 Apr;43(4):546–550. doi: 10.1038/bjc.1981.79

A marker for hypoxic cells in tumours with potential clinical applicability.

J D Chapman, A J Franko, J Sharplin

PMCID: PMC2010627 PMID: 7236492

546

Images in this article

Fig. 1
on p.547

Fig. 2
on p.547

Fig. 3
on p.548

Fig. 4
on p.548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Adams G. E. Chemical radiosensitization of hypoxic cells. Br Med Bull. 1973 Jan;29(1):48–53. doi: 10.1093/oxfordjournals.bmb.a070956. [DOI] [PubMed] [Google Scholar]
Bush R. S., Jenkin R. D., Allt W. E., Beale F. A., Bean H., Dembo A. J., Pringle J. F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl. 1978 Jun;3:302–306. [PMC free article] [PubMed] [Google Scholar]
Chapman J. D., Reuvers A. P., Borsa J., Petkau A., McCalla D. R. Nitrofurans as radiosensitizers of hypoxic mammalian cells. Cancer Res. 1972 Dec;32(12):2616–2624. [PubMed] [Google Scholar]
GRAY L. H., CONGER A. D., EBERT M., HORNSEY S., SCOTT O. C. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953 Dec;26(312):638–648. doi: 10.1259/0007-1285-26-312-638. [DOI] [PubMed] [Google Scholar]
Henk J. M., Smith C. W. Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial. Lancet. 1977 Jul 16;2(8029):104–105. doi: 10.1016/s0140-6736(77)90117-9. [DOI] [PubMed] [Google Scholar]
McCalla D. R., Reuvers A., Kaiser C. Mode of action of nitrofurazone. J Bacteriol. 1970 Dec;104(3):1126–1134. doi: 10.1128/jb.104.3.1126-1134.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
Urtasun R., Band P., Chapman J. D., Feldstein M. L., Mielke B., Fryer C. Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med. 1976 Jun 17;294(25):1364–1367. doi: 10.1056/NEJM197606172942503. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES